Day One Biopharmaceutical...

NASDAQ: DAWN · Real-Time Price · USD
6.76
0.51 (8.16%)
At close: Aug 15, 2025, 3:59 PM
6.75
-0.15%
After-hours: Aug 15, 2025, 06:48 PM EDT

Day One Biopharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-95.5M -188.92M -142.18M -72.75M
Depreciation & Amortization
2.03M 383K 531K 199K
Stock-Based Compensation
48.26M 39.34M 27.24M 13.32M
Other Working Capital
42.91M 7.1M 8.05M 1.15M
Other Non-Cash Items
-59.39M -7.08M -2.03M 8M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
26.48M 9.42M 6.56M 2.69M
Operating Cash Flow
-78.11M -146.85M -109.87M -48.54M
Capital Expenditures
-2.17M -3.22M -26K -8M
Cash Acquisitions
n/a n/a 255.05K n/a
Purchase of Investments
-658.62M -443.84M -394.21M n/a
Sales Maturities Of Investments
393.89M 575.44M 139.16M n/a
Other Investing Acitivies
35.9M -3M -255.05K -8M
Investing Cash Flow
-230.99M 128.38M -255.07M -8M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
25.11M 2.59M 4.29M 318K
Financial Cash Flow
203.29M 164M 165.9M 297.12M
Net Cash Flow
-105.82M 145.52M -199.05M 240.58M
Free Cash Flow
-80.28M -150.08M -109.9M -56.54M